Hims & Hers Health, Inc. (HIMS): Price and Financial Metrics
GET POWR RATINGS... FREE!
HIMS Stock Price Chart Interactive Chart >
HIMS Price/Volume Stats
|Current price||$8.20||52-week high||$25.40|
|Prev. close||$8.19||52-week low||$7.96|
|Day high||$8.32||Avg. volume||1,898,606|
|50-day MA||$11.22||Dividend yield||N/A|
|200-day MA||$12.96||Market Cap||1.57B|
Hims & Hers Health, Inc. (HIMS) Company Bio
Hims & Hers Health, Inc. provides health care software solutions. The Company offers multi-specialty telehealth platform that connects consumers to licensed healthcare providers, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, and primary care. Hims & Hers Health serves customers in the United States.
HIMS Latest News Stream
|Loading, please wait...|
HIMS Latest Social Stream
View Full HIMS Social Stream
Latest HIMS News From Around the Web
Below are the latest news stories about Hims & Hers Health Inc that investors may wish to consider to help them evaluate HIMS as an investment opportunity.
SAN FRANCISCO, July 22, 2021--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release fiscal second quarter financial results on Wednesday, August 11, 2021 after market close, with a conference call to follow at 5:00 p.m. E.T.
Gainers: Pop Culture Group Co. (CPOP) +18%. LifeVantage (LFVN) +15%. PlayAGS (AGS) +12%. AMC Entertainment Holdings (AMC) +12%. The Duckhorn Portfolio (NAPA) +11%.Losers: Mer Telemanagement Solutions (MTSL) -18%. MediaCo Holding (MDIA) -12%. Liquid Media Group (YVR) -11%. Takung Art Co. (TKAT) -9%. Hims & Hers Health (HIMS) -8%....
The Pandemic’s Impact on Americans’ Mental Health: New Hims & Hers Survey Shows 70% Remain Anxious Around Post-Pandemic ‘Normal’, Half Have Considered Therapy for the First Time
SAN FRANCISCO, July 13, 2021--Hims & Hers releases survey findings on the pandemic's impact on Americans' mental health.
SAN FRANCISCO, July 09, 2021--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company," NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced that it will redeem all of its outstanding warrants (the "Warrants") to purchase shares of the Company’s Class A common stock, par value $0.0001 per share (the "Common Stock"), that were issued under the Warrant Agreement, dated July 22, 2019 (the "Warrant
SAN FRANCISCO, July 08, 2021--Hims & Hers expands focus on sexual health with new product bundles.
HIMS Price Returns